Peripheral Neuropathy Clinical Trial
Official title:
The Effect of Plantar Vibration on the Progression of Peripheral Neuropathy
The purpose of this study is to assess the effect of vibration of the plantar surface of the foot on peripheral neuropathy.
Background: Peripheral neuropathy has a prevalence approaching 10% in the general
population. The pathophysiology of peripheral neuropathy is poorly understood or
undetermined. While many causes of peripheral neuropathy are known, a significant number of
cases are idiopathic. The most common cause of neuropathy relates to glucose intolerance or
overt diabetes. Exogenous factors such as smoking constrict small cutaneous blood vessels,
thereby inhibiting small nerve fiber nutrition. Symptoms of neuropathy include numbness,
pain, difficulty with balance, lack of temperature perception, and weakness which can lead
to significant disability. Classification of neuropathies can be made based on nerve fiber
size: large fiber, small fiber and mixed large and small fiber types. Plantar vibration
which affects large fibers has been demonstrated to enhance peripheral and systemic blood
flow, peripheral lymphatic and venous drainage (Stewart, Karman, Montgomery, & McLeod,
2005). Since fluid retention in axons, nerve sheaths and surrounding connective tissues may
contribute to neuropathy, it is hypothesized that plantar vibration may repair the small
peripheral fibers, thereby improving the symptoms of neuropathy.
Purposes:
1. To assess the effect of plantar vibration on regeneration of small peripheral nerve
fibers, peripheral neuropathy and quality of life in patients with diagnosed peripheral
neuropathy.
2. To assess the correlation of health history, demographic variables, diet, alcohol and
smoking history with small fiber neuropathy analysis by skin biopsy and plantar
vibration.
Design: The study will employ a cross-over experimental design with subjects acting as their
own controls. Independent variables are the plantar stimulation (intervention), and the
characteristics of the subjects that include health history, demographic variables, self
reported diet, alcohol, and smoking history, as well as urinary cotinine (a quantitative
measure of smoking history). The dependent variables are the assay of intraepidermal nerve
fibers in small-fiber neuropathy, clinical assessment of peripheral neuropathy, serum levels
of Hgb A1C, and quality of life measurement.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05152368 -
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Trigeminal Neuralgia and Peripheral Neuropathy
|
Phase 1 | |
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Completed |
NCT02549534 -
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer
|
N/A | |
Active, not recruiting |
NCT02701075 -
MC5-A Scrambler Therapy for the Treatment of Chronic Neuropathic Extremity Pain
|
N/A | |
Completed |
NCT01196442 -
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
|
N/A | |
Completed |
NCT00763087 -
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
|
N/A | |
Completed |
NCT00079807 -
Painful HIV Neuropathy and Alpha-Lipoic Acid
|
Phase 1/Phase 2 | |
Completed |
NCT03292328 -
Yoga for Symptoms of Nerve Damage Caused by Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05379140 -
Use Therapeutic Chinese Massage to Treat Peripheral Neuropathy in People With HIV
|
N/A | |
Recruiting |
NCT05673746 -
Acupuncture in Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer
|
N/A | |
Completed |
NCT05189535 -
"Prevention of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients"
|
Phase 2/Phase 3 | |
Recruiting |
NCT06219590 -
Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Therapy
|
N/A | |
Enrolling by invitation |
NCT05595109 -
Role of Silymarin in Chemotherapy Toxicity and Cognition Improvement in Breast Cancer Patients
|
Phase 2/Phase 3 | |
Completed |
NCT05916118 -
Exercise and Oxaliplatin-induced Peripheral Neuropathy
|
N/A | |
Withdrawn |
NCT03881748 -
Clinical Trial of Acupuncture for Chemotherapy-Induced Peripheral Neuropathy
|
N/A | |
Not yet recruiting |
NCT03112057 -
Visualize Nociceptor Changes in Neuropathic Human
|
N/A | |
Completed |
NCT02936843 -
Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
|
Phase 2/Phase 3 | |
Terminated |
NCT01458015 -
Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain
|
Phase 4 | |
Completed |
NCT01006408 -
Treatment Trial Using Low Level Laser Therapy (LLLT) for Treatment of Chemotherapy Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT00471445 -
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
|
Phase 3 |